Daniel Couto
Directeur des opérations chez Vedanta Biosciences, Inc.
Profil
Daniel E.
Couto is currently the Chief Operating Officer at Vedanta Biosciences, Inc. He previously worked as a Director at ImmuCell Corp., Sumitomo Pharma America, Inc., AFG Biosolutions, Inc., rEVO Biologics, Inc., and as the Vice President-Commercial Manufacturing Operations at Organon Pharma (UK) Ltd.
He also served as the Senior Vice President-Product Development at ContraFect Corp.
from 2014 to 2016.
Couto completed his undergraduate degree from Rensselaer Polytechnic Institute.
Postes actifs de Daniel Couto
| Sociétés | Poste | Début |
|---|---|---|
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Directeur des opérations | 01/10/2019 |
Anciens postes connus de Daniel Couto
| Sociétés | Poste | Fin |
|---|---|---|
| CONTRAFECT CORPORATION | Corporate Officer/Principal | 22/04/2016 |
AFG Biosolutions, Inc.
 AFG Biosolutions, Inc. Pharmaceuticals: MajorHealth Technology AFG Biosolutions, Inc. is a private company that develops medical defenses against bio-terrorist agents. The company is based in Manassas, VA. AFG Biosolutions was acquired by Advanced Biosystems, Inc. /Alibek & Gilluly/ from Analex Corp. on November 17, 2004 for $1 million. | Directeur/Membre du Conseil | - |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Directeur/Membre du Conseil | - |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Corporate Officer/Principal | - |
| IMMUCELL CORPORATION | Directeur/Membre du Conseil | - |
Formation de Daniel Couto
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IMMUCELL CORPORATION | Health Technology |
| CONTRAFECT CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
| Nuvelo, Inc. | Health Technology |
AFG Biosolutions, Inc.
AFG Biosolutions, Inc. Pharmaceuticals: MajorHealth Technology AFG Biosolutions, Inc. is a private company that develops medical defenses against bio-terrorist agents. The company is based in Manassas, VA. AFG Biosolutions was acquired by Advanced Biosystems, Inc. /Alibek & Gilluly/ from Analex Corp. on November 17, 2004 for $1 million. | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
